Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$89.10
+1.90%
Mkt Cap $6.33B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (55 analysts)
$117.31
Range $90.00 – $138.00
Implied Upside
+31.7%
Consensus $117.31 vs current $89.10
NASDAQ·Healthcare·Biotechnology
$89.10
+1.90%
Mkt Cap $6.33B
Buy
9
Hold
0
Sell
0
Price Target (55 analysts)
$117.31
Range $90.00 – $138.00
+31.7%
Consensus $117.31 vs current $89.10